2 research outputs found
ΠΠ΅Π΄ΠΈΠ°ΡΠΎΡΠ½ΡΠ΅ Π²Π·Π°ΠΈΠΌΠΎΠ΄Π΅ΠΉΡΡΠ²ΠΈΡ ΠΏΡΠΈ ΠΎΡΡΡΠΎΠΌ ΡΠ΅ΡΠΏΠΈΡΠ°ΡΠΎΡΠ½ΠΎΠΌ Π΄ΠΈΡΡΡΠ΅ΡΡ-ΡΠΈΠ½Π΄ΡΠΎΠΌΠ΅
The review of literature covers the interaction of numerous mediators that are initiators and major motive forces of the occurrence and development of acute respiratory distress syndrome (ARDS). The major mediator families include cytokines, mediators of lipid origin, components of the extracellular matrix, mediators of the oxidative and antioxidative systems, proteinases, and components of the coagulation system. The representatives of each of the above families play an important role at each developmental stage of ARDS: an increase in the permeability of pulmonary capillaries, chemotaxis of neutrophilic granulocytes, macrophages, and lymphocytes, secondary damage to endotheliocytes, pulmonary epithelium and surfactant, occurrence of pulmonary hypertension, and development of pulmonary fibrosis in late-stage ARDS. The intensity of clinical manifestations depends on the interaction between pro- and anti-inflammatory mediators, which starts at the earliest stages of their development. Searches for specific antagonists of proinflammatory mediators and their receptors were noted to be of importance for further clinical application and, first all, development of more effective treatments for ARDS.Β Π ΠΎΠ±Π·ΠΎΡΠ΅ Π»ΠΈΡΠ΅ΡΠ°ΡΡΡΡ ΠΎΡΠ²Π΅ΡΠ΅Π½Ρ Π²ΠΎΠΏΡΠΎΡΡ Π²Π·Π°ΠΈΠΌΠΎΠ΄Π΅ΠΉΡΡΠ²ΠΈΡ ΠΌΠ½ΠΎΠ³ΠΎΡΠΈΡΠ»Π΅Π½Π½ΡΡ
ΠΌΠ΅Π΄ΠΈΠ°ΡΠΎΡΠΎΠ², ΡΠ²Π»ΡΡΡΠΈΡ
ΡΡ ΠΈΠ½ΠΈΡΠΈΠ°ΡΠΎΡΠ°ΠΌΠΈ ΠΈ ΠΎΡΠ½ΠΎΠ²Π½ΡΠΌΠΈ Π΄Π²ΠΈΠΆΡΡΠΈΠΌΠΈ ΡΡΠΈΠΌΡΠ»Π°ΠΌΠΈ Π²ΠΎΠ·Π½ΠΈΠΊΠ½ΠΎΠ²Π΅Π½ΠΈΡ ΠΈ ΡΠ°Π·Π²ΠΈΡΠΈΡ ΠΎΡΡΡΠΎΠ³ΠΎ ΡΠ΅ΡΠΏΠΈΡΠ°ΡΠΎΡΠ½ΠΎΠ³ΠΎ Π΄ΠΈΡΡΡΠ΅ΡΡ-ΡΠΈΠ½Π΄ΡΠΎΠΌΠ°. ΠΡΠ½ΠΎΠ²Π½ΡΠ΅ ΡΠ΅ΠΌΠ΅ΠΉΡΡΠ²Π° ΠΌΠ΅Π΄ΠΈΠ°ΡΠΎΡΠΎΠ² Π²ΠΊΠ»ΡΡΠ°ΡΡ ΡΠΈΡΠΎΠΊΠΈΠ½Ρ, ΠΌΠ΅Π΄ΠΈΠ°ΡΠΎΡΡ Π»ΠΈΠΏΠΈΠ΄Π½ΠΎΠ³ΠΎ ΠΏΡΠΎΠΈΡΡ
ΠΎΠΆΠ΄Π΅Π½ΠΈΡ, ΠΊΠΎΠΌΠΏΠΎΠ½Π΅Π½ΡΡ Π²Π½Π΅ΠΊΠ»Π΅ΡΠΎΡΠ½ΠΎΠ³ΠΎ ΠΌΠ°ΡΡΠΈΠΊ-ΡΠ°, ΠΌΠ΅Π΄ΠΈΠ°ΡΠΎΡΡ ΠΎΠΊΡΠΈΠ΄Π°Π½ΡΠ½ΠΎΠΉ ΠΈ Π°Π½ΡΠΈΠΎΠΊΡΠΈΠ΄Π°Π½ΡΠ½ΠΎΠΉ ΡΠΈΡΡΠ΅ΠΌ, ΠΏΡΠΎΡΠ΅ΠΈΠ½Π°Π·Ρ ΠΈ ΠΊΠΎΠΌΠΏΠΎΠ½Π΅Π½ΡΡ ΡΠΈΡΡΠ΅ΠΌΡ ΡΠ²Π΅ΡΡΡΠ²Π°Π½ΠΈΡ. ΠΡΠ΅Π΄ΡΡΠ°Π²ΠΈΡΠ΅Π»ΠΈ ΠΊΠ°ΠΆΠ΄ΠΎΠ³ΠΎ ΠΈΠ· ΡΠΊΠ°Π·Π°Π½Π½ΡΡ
ΡΠ΅ΠΌΠ΅ΠΉΡΡΠ² ΠΈΠ³ΡΠ°ΡΡ Π²Π°ΠΆΠ½ΡΡ ΡΠΎΠ»Ρ Π½Π° ΠΊΠ°ΠΆΠ΄ΠΎΠΌ ΠΈΠ· ΡΡΠ°ΠΏΠΎΠ² ΡΠ°Π·Π²ΠΈΡΠΈΡ ΠΠ ΠΠ‘: ΠΏΠΎΠ²ΡΡΠ΅Π½ΠΈΠ΅ ΠΏΡΠΎΠ½ΠΈΡΠ°Π΅ΠΌΠΎΡΡΠΈ Π»Π΅Π³ΠΎΡΠ½ΡΡ
ΠΊΠ°ΠΏΠΈΠ»Π»ΡΡΠΎΠ², Ρ
Π΅ΠΌΠΎΡΠ°ΠΊΡΠΈΡ Π½Π΅ΠΉΡΡΠΎΡΠΈΠ»ΡΠ½ΡΡ
Π³ΡΠ°Π½ΡΠ»ΠΎΡΠΈΡΠΎΠ², ΠΌΠ°ΠΊΡΠΎΡΠ°Π³ΠΎΠ² ΠΈ Π»ΠΈΠΌΡΠΎΡΠΈΡΠΎΠ², Π²ΡΠΎΡΠΈΡΠ½ΠΎΠ΅ ΠΏΠΎΠ²ΡΠ΅ΠΆΠ΄Π΅Π½ΠΈΠ΅ ΡΠ½Π΄ΠΎΡΠ΅Π»ΠΈΠΎΡΠΈΡΠΎΠ², Π»Π΅Π³ΠΎΡΠ½ΠΎΠ³ΠΎ ΡΠΏΠΈΡΠ΅Π»ΠΈΡ ΠΈ ΡΡΡΡΠ°ΠΊΡΠ°Π½ΡΠ°, Π²ΠΎΠ·Π½ΠΈΠΊΠ½ΠΎΠ²Π΅Π½ΠΈΠ΅ Π»Π΅Π³ΠΎΡΠ½ΠΎΠΉ Π³ΠΈΠΏΠ΅ΡΡΠ΅Π½Π·ΠΈΠΈ, Π° ΡΠ°ΠΊΠΆΠ΅ ΡΠ°Π·Π²ΠΈΡΠΈΠ΅ Π»Π΅Π³ΠΎΡΠ½ΠΎΠ³ΠΎ ΡΠΈΠ±ΡΠΎΠ·Π° Π² Π·Π°Π²Π΅ΡΡΠ°ΡΡΠ΅ΠΉ ΡΡΠ°Π΄ΠΈΠΈ ΠΠ ΠΠ‘. ΠΠ½ΡΠ΅Π½ΡΠΈΠ²Π½ΠΎΡΡΡ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΏΡΠΎΡΠ²Π»Π΅Π½ΠΈΠΉ Π·Π°Π²ΠΈΡΠΈΡ ΠΎΡ Π²Π·Π°ΠΈΠΌΠΎΠ΄Π΅ΠΉΡΡΠ²ΠΈΡ ΠΌΠ΅ΠΆΠ΄Ρ ΠΏΡΠΎ- ΠΈ ΠΏΡΠΎΡΠΈΠ²ΠΎΠ²ΠΎΡΠΏΠ°Π»ΠΈΡΠ΅Π»ΡΠ½ΡΠΌΠΈ ΠΌΠ΅Π΄ΠΈΠ°ΡΠΎΡΠ°ΠΌΠΈ, Π½Π°ΡΠΈΠ½Π°ΡΡΠ΅Π³ΠΎΡΡ Π½Π° ΡΠ°ΠΌΡΡ
ΡΠ°Π½Π½ΠΈΡ
ΡΡΠ°ΠΏΠ°Ρ
ΠΈΡ
ΡΠ°Π·Π²ΠΈΡΠΈΡ. ΠΡΠΌΠ΅ΡΠ΅Π½Π° Π²Π°ΠΆΠ½Π°Ρ ΡΠΎΠ»Ρ ΠΏΠΎΠΈΡΠΊΠ° ΡΠΏΠ΅ΡΠΈΡΠΈΡΠ΅ΡΠΊΠΈΡ
Π°Π½ΡΠ°Π³ΠΎΠ½ΠΈΡΡΠΎΠ² ΠΏΡΠΎΠ²ΠΎΡΠΏΠ°Π»ΠΈΡΠ΅Π»ΡΠ½ΡΡ
ΠΌΠ΅Π΄ΠΈΠ°ΡΠΎΡΠΎΠ² ΠΈ ΠΈΡ
ΡΠ΅ΡΠ΅ΠΏΡΠΎΡΠΎΠ² Π΄Π»Ρ Π΄Π°Π»ΡΠ½Π΅ΠΉΡΠ΅Π³ΠΎ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΡ Π² ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΏΡΠ°ΠΊΡΠΈΠΊΠ΅ ΠΈ, ΠΏΡΠ΅ΠΆΠ΄Π΅ Π²ΡΠ΅Π³ΠΎ, Π΄Π»Ρ ΡΠ°Π·ΡΠ°Π±ΠΎΡΠΊΠΈ Π½ΠΎΠ²ΡΡ
, Π±ΠΎΠ»Π΅Π΅ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΡΡ
ΠΌΠ΅ΡΠΎΠ΄ΠΎΠ² Π»Π΅ΡΠ΅Π½ΠΈΡ ΠΠ ΠΠ‘.
Mediator Interactions in Acute Respiratory Distress Syndrome
The review of literature covers the interaction of numerous mediators that are initiators and major motive forces of the occurrence and development of acute respiratory distress syndrome (ARDS). The major mediator families include cytokines, mediators of lipid origin, components of the extracellular matrix, mediators of the oxidative and antioxidative systems, proteinases, and components of the coagulation system. The representatives of each of the above families play an important role at each developmental stage of ARDS: an increase in the permeability of pulmonary capillaries, chemotaxis of neutrophilic granulocytes, macrophages, and lymphocytes, secondary damage to endotheliocytes, pulmonary epithelium and surfactant, occurrence of pulmonary hypertension, and development of pulmonary fibrosis in late-stage ARDS. The intensity of clinical manifestations depends on the interaction between pro- and anti-inflammatory mediators, which starts at the earliest stages of their development. Searches for specific antagonists of proinflammatory mediators and their receptors were noted to be of importance for further clinical application and, first all, development of more effective treatments for ARDS